MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-07-2024
Axonics Modulation Technologies Revenue 2011-2025 | AXNX
Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.
Traditionally defined as follows:Revenue = Price * Quantity of productsRevenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]
This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.
Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.
Annual Revenue Axonics Modulation Technologies
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 274 M | 180 M | 112 M | 13.8 M | 707 K | 128 K | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 274 M | 128 K | 96.7 M |
Quarterly Revenue Axonics Modulation Technologies
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116 M | 115 M | 91.4 M | - | 93.1 M | 92.9 M | 70.6 M | - | 70.4 M | 69 M | 48.4 M | - | 46.9 M | 45.9 M | 34.4 M | - | 35.2 M | 15.2 M | 26.3 M | - | 1.31 M | 1.49 M | 1.08 M | - | 201 K | 12 K | - | - | 128 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 116 M | 12 K | 46.4 M |
References
- Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).
Revenue of other stocks in the Medical devices industry
| Issuer | Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
848 M | - | - | $ 17.2 B |  USA |
 |
Acutus Medical
AFIB
|
7.16 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
6.02 M | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
172 M | - | - | $ 1.77 B | USA |
 |
Apyx Medical Corporation
APYX
|
52.3 M | $ 3.47 | -3.61 % | $ 120 M | USA |
 |
Boston Scientific Corporation
BSX
|
16.7 B | $ 95.88 | -0.23 % | $ 141 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
1.59 M | - | -5.86 % | $ 30.6 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
443 M | $ 9.44 | -1.1 % | $ 678 M |  Israel |
 |
Bio-Rad Laboratories
BIO
|
2.57 B | $ 301.88 | 0.04 % | $ 8.52 B | USA |
 |
Apollo Endosurgery
APEN
|
76.9 M | - | - | $ 475 M | USA |
 |
Conformis
CFMS
|
62 M | - | - | $ 16.4 M | USA |
 |
Eargo
EAR
|
37.2 M | - | - | $ 10.2 M | USA |
 |
BioSig Technologies
BSGM
|
40 K | - | 37.08 % | $ 85.7 M | USA |
 |
Cardiovascular Systems
CSII
|
236 M | - | 0.15 % | $ 844 M | USA |
 |
Bruker Corporation
BRKR
|
3.37 B | $ 47.67 | -0.94 % | $ 7.1 K | USA |
 |
Cutera
CUTR
|
49.5 M | - | -10.19 % | $ 1.99 M | USA |
 |
Abbott Laboratories
ABT
|
42 B | $ 124.51 | -0.27 % | $ 217 B | USA |
 |
InMode Ltd.
INMD
|
358 M | $ 14.55 | 0.55 % | $ 1.15 B | Israel |
 |
EDAP TMS S.A.
EDAP
|
44.1 M | $ 3.39 | 14.2 % | $ 126 M |  France |
 |
CryoLife, Inc.
CRY
|
253 M | - | -4.14 % | $ 702 M | USA |
 |
LivaNova PLC
LIVN
|
1.25 B | $ 62.83 | -0.4 % | $ 3.41 B |  Britain |
|
LENSAR
LNSR
|
53.5 M | $ 12.0 | -0.09 % | $ 138 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.25 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
41 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
62.5 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
2.55 M | - | - | $ 111 M |  Canada |
 |
Orthofix Medical
OFIX
|
799 M | $ 15.09 | -0.46 % | $ 575 M |  Curacao |
 |
Dynatronics Corporation
DYNT
|
27.4 M | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
80.6 M | - | - | $ 955 M | USA |
 |
PAVmed
PAVM
|
2.5 M | $ 0.28 | -0.9 % | $ 2.02 M | USA |
 |
IRIDEX Corporation
IRIX
|
51.9 M | $ 1.2 | 5.47 % | $ 19.4 M | USA |
 |
Second Sight Medical Products
EYES
|
1 K | - | -0.97 % | $ 54.4 M | USA |
 |
Quanterix Corporation
QTRX
|
122 M | $ 6.48 | -2.11 % | $ 244 M | USA |
 |
Align Technology
ALGN
|
4 B | $ 157.08 | -0.48 % | $ 11.8 B | USA |
 |
NanoVibronix
NAOV
|
2.56 M | - | - | $ 1.08 M | USA |
 |
Accuray Incorporated
ARAY
|
459 M | $ 0.82 | -4.19 % | $ 84.3 M | USA |
 |
IRadimed Corporation
IRMD
|
73.2 M | $ 97.63 | 0.59 % | $ 1.24 B | USA |
 |
Avinger
AVGR
|
7.65 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
31.4 M | $ 14.03 | -3.17 % | $ 379 M | USA |
 |
FONAR Corporation
FONR
|
97.6 M | $ 14.47 | -0.41 % | $ 94.8 M | USA |
 |
AxoGen
AXGN
|
187 M | $ 32.21 | -1.32 % | $ 1.43 B | USA |
 |
Sintx Technologies
SINT
|
2.63 M | $ 3.6 | 1.69 % | $ 13.5 M | USA |
 |
GBS
GBS
|
3.05 M | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
1.31 B | $ 40.21 | 0.42 % | $ 1.24 B | USA |
 |
Sensus Healthcare
SRTS
|
41.8 M | $ 3.82 | 0.68 % | $ 62.3 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
205 M | $ 17.22 | -1.09 % | $ 397 M | USA |